- Climb Bio press release (NASDAQ:CLYM): Q1 GAAP EPS of -$0.31.
- Cash Position: Cash, cash equivalents and marketable securities were $197.8 million as of March 31, 2025. Cash, cash equivalents and marketable securities are expected to fund operations through 2027.
Climb Bio GAAP EPS of -$0.31
.png)
2 months ago
4
Related
HSBC taps John McDonald from UBS to oversee marketing
6 minutes ago
0
Life Time Group Non-GAAP EPS of $0.37 beats by $0.01, revenu...
12 minutes ago
0
Jacobs Engineering gives mixed Q3 results, raises FY outlook...
13 minutes ago
0
Yum China gains after seeing same-store sales turn positive ...
14 minutes ago
0
Sally Beauty Non-GAAP EPS of $0.51, revenue of $933M
15 minutes ago
0
Pfizer Non-GAAP EPS of $0.78 beats by $0.21, revenue of $14....
16 minutes ago
0
Popular
Listen to the sounds of a black hole with these NASA sonific...
2 months ago
75
Palm Springs Bombing: What We Know About Fertility Clinic Ex...
2 months ago
66
Oil futures fall as Saudi Arabia said to seek more big OPEC ...
2 months ago
49
This is the next historical period I want to see in Assassin...
2 months ago
44
UK's unemployment rate rises to 4.6% in April
1 month ago
41
English (US) · © Insaro Search Engines 2025. All rights are reserved